Compare Edwards Lifesciences Corporation Common Stock (EW) vs NIO Inc. (NIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs NIO Inc. — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while NIO Inc. trades at $3.47 (market cap $8.67B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 5.7× NIO Inc.'s market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| EW | NIO | |
|---|---|---|
Market Cap | $49.44B | $8.67B |
Volume | 3,508,027 | 25,622,800 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $7.46 |
52-Week Low | $72.65 | $3.37 |
Enterprise Value | $45.90B | $6.57B |
Typical Hold Time | — | 81 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NIO trades at $3.41, down 2.01% today and near its 52-week low of $3.38. The stock shows bearish technical signals with negative moving averages, though oscillators are neutral. Fundamentally, revenue grew to $87.49B in 2025 with improving net margin to -17.8%, but the company remains unprofitable with negative ROE of -332.77%. Recent news highlights a strategic battery-swap partnership with Geely, valued at $2.38B, which could expand NIO's charging network reach.
The outlook remains challenging amid a brutal EV price war in China, though analyst consensus is bullish with a $6.23 price target implying 83% upside. Key risks include persistent losses, high debt, and intense competition. Institutional sentiment is mixed with 50% buy ratings, but the stock's current valuation at 0.51 P/S may attract value investors betting on a long-term turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
